Targeting attenuated cytokines to tumor cells results in robust tumor killing with significantly reduced off-target activity: Anti-CD38-Attenukine (TM)

Pogue Sarah; Taura Tetsuya; Bi Mingying; Mikese Glen; Yun Yong; Sho Angela; Behrens Collette; Stevens Maxwell; Domagala Teresa; Sokolovsky Maya; Hallak Hussein; Rosenstock Moti; Doyle Anthony; Wilson David

首页> 外文期刊>Cytokine >Targeting attenuated cytokines to tumor cells results in robust tumor killing with significantly reduced off-target activity: Anti-CD38-Attenukine (TM)

【24h】

Targeting attenuated cytokines to tumor cells results in robust tumor killing with significantly reduced off-target activity: Anti-CD38-Attenukine (TM)

机译：将减毒的细胞因子靶向肿瘤细胞可导致强大的肿瘤杀伤力，并显着降低脱靶活性：Anti-CD38-Attenukine（TM）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cytokine》 |2015年第1期|共1页
作者
Pogue Sarah; Taura Tetsuya; Bi Mingying; Mikese Glen; Yun Yong; Sho Angela; Behrens Collette; Stevens Maxwell; Domagala Teresa; Sokolovsky Maya; Hallak Hussein; Rosenstock Moti; Doyle Anthony; Wilson David;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类细胞生物学;
关键词

相似文献

外文文献
中文文献
专利

1. Targeting attenuated cytokines to tumor cells results in robust tumor killing with significantly reduced off-target activity: Anti-CD38-Attenukine (TM) [J] . Pogue Sarah, Taura Tetsuya, Bi Mingying, Cytokine . 2015,第1期

机译：将减毒的细胞因子靶向肿瘤细胞可导致强大的肿瘤杀伤力，并显着降低脱靶活性：Anti-CD38-Attenukine（TM）
2. TARGETING ATTENUATED CYTOKINES TO TUMOR CELLS RESULTS IN ENHANCED TUMOR KILLING WITH REDUCED OFF-TARGET ACTIVITY: ANTI-CD38-ATTENUKINE (TM) CASE STUDY [J] . Pogue S., Taura T., Bi M., Cytokine . 2016,第Null期

机译：将减毒的细胞因子靶向于肿瘤细胞，从而增强了杀伤力，降低了靶标活性，从而杀死肿瘤：抗CD38-Atenenukine（TM）案例研究
3. TARGETING ATTENUATED CYTOKINES TO TUMOR CELLS RESULTS IN ENHANCED TUMOR KILLING WITH REDUCED OFF-TARGET ACTIVITY: ANTI-CD38-ATTENUKINE (TM) CASE STUDY [J] . Pogue S., Taura T., Bi M., Cytokine . 2016,第Null期

机译：靶向减毒细胞因子对肿瘤细胞导致增强的肿瘤杀死，减少了偏移活动：抗CD38-睾丸（TM）案例研究
4. Anti-breast tumor activities of CpG ODN-activated dendritic cells co-cultured with cytokine-induced killer cells in vitro and in vivo [C] . Gabriele Ghisellini Asian Pacific Confederation of Chemical Engineering congress . 2008

机译：CpG ODN激活的树突状细胞与细胞因子诱导的杀伤细胞在体外和体内共培养的抗乳腺癌肿瘤活性
5. Murine Lymphokine-activated Killer(LAK)Cells: Establishment of LAK Cell Clones,Analysis of Target Cell Killing Mechanism and Application for Tumor Therapy [D] . 加藤和則 1991

机译：小鼠淋巴因子激活的杀伤（LAK）细胞：LAK细胞克隆的建立，靶细胞杀伤机制的分析及其在肿瘤治疗中的应用
6. Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity [O] . Sarah L. Pogue, Tetsuya Taura, Mingying Bi, -1

机译：用CD38抗体靶向减毒的干扰素α到骨髓瘤细胞诱导有效的肿瘤消退降低脱靶活性
7. Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity. [O] . Sarah L Pogue, Tetsuya Taura, Mingying Bi, 2016

机译：用CD38抗体靶向减毒干扰素-α至骨髓瘤细胞诱导有效的肿瘤消退，同时降低脱靶活性。
8. Targeting Killing of Breast Tumor Stem Cells [R] . Chen, S. 2005

机译：靶向杀死乳腺肿瘤干细胞

Targeting attenuated cytokines to tumor cells results in robust tumor killing with significantly reduced off-target activity: Anti-CD38-Attenukine (TM)

著录项

相似文献

相关主题

期刊订阅